中国药理学通报
中國藥理學通報
중국약이학통보
CHINESE PHARMACOLOGICAL BULLETIN
2015年
4期
582-585
,共4页
固相萃取法%氯米帕明%地西泮%奥沙西泮%氯硝西泮%阿普唑仑%高效液相色谱法
固相萃取法%氯米帕明%地西泮%奧沙西泮%氯硝西泮%阿普唑崙%高效液相色譜法
고상췌취법%록미파명%지서반%오사서반%록초서반%아보서륜%고효액상색보법
solid phase extraction%clomipramine%diazepam%oxazepam%clonazepam%alprazolam%HPLC
目的:建立同时测定血浆中氯米帕明和4种苯二氮类药物奥沙西泮、地西泮、氯硝西泮、阿普唑仑浓度的固相萃取-高效液相色谱法(HPLC)。方法XTerraC8RP(4.6mm×150mm,5μm)为色谱柱,磷酸盐缓冲液(50mmol·L-1,pH3.0)和乙腈(73.2:26.8,V/V)为流动相,流速1.2mL·min-1,柱温45℃;检测波长220nm,血浆经C1固相萃取柱预处理。结果线性范围分别为:阿普唑仑、氯硝西泮5.0~200.0μg·L-1,地西泮10.0~500.0μg·L-1,氯米帕明20.0~500.0μg·L-1,奥沙西泮7.5~2000μg·L-1,相关系数均大于0.9994;最低检测限分别为:阿普唑仑1.5μg·L-1、氯硝西泮1.4μg·L-1、地西泮3.0μg·L-1、氯米帕明5.5μg·L-1、奥沙西泮2.2μg·L-1;日内及日间精密度(CV%)分别为2.2%~12.6%、2.1%~13.2%,偏差-10.6%~14.6%,提取回收率81.1%~100.1%。结论该法可用于临床血浆中氯米帕明和4种苯二氮类药物的同时检测,方法新颖、灵敏、经济,结果准确、可靠。
目的:建立同時測定血漿中氯米帕明和4種苯二氮類藥物奧沙西泮、地西泮、氯硝西泮、阿普唑崙濃度的固相萃取-高效液相色譜法(HPLC)。方法XTerraC8RP(4.6mm×150mm,5μm)為色譜柱,燐痠鹽緩遲液(50mmol·L-1,pH3.0)和乙腈(73.2:26.8,V/V)為流動相,流速1.2mL·min-1,柱溫45℃;檢測波長220nm,血漿經C1固相萃取柱預處理。結果線性範圍分彆為:阿普唑崙、氯硝西泮5.0~200.0μg·L-1,地西泮10.0~500.0μg·L-1,氯米帕明20.0~500.0μg·L-1,奧沙西泮7.5~2000μg·L-1,相關繫數均大于0.9994;最低檢測限分彆為:阿普唑崙1.5μg·L-1、氯硝西泮1.4μg·L-1、地西泮3.0μg·L-1、氯米帕明5.5μg·L-1、奧沙西泮2.2μg·L-1;日內及日間精密度(CV%)分彆為2.2%~12.6%、2.1%~13.2%,偏差-10.6%~14.6%,提取迴收率81.1%~100.1%。結論該法可用于臨床血漿中氯米帕明和4種苯二氮類藥物的同時檢測,方法新穎、靈敏、經濟,結果準確、可靠。
목적:건립동시측정혈장중록미파명화4충분이담류약물오사서반、지서반、록초서반、아보서륜농도적고상췌취-고효액상색보법(HPLC)。방법XTerraC8RP(4.6mm×150mm,5μm)위색보주,린산염완충액(50mmol·L-1,pH3.0)화을정(73.2:26.8,V/V)위류동상,류속1.2mL·min-1,주온45℃;검측파장220nm,혈장경C1고상췌취주예처리。결과선성범위분별위:아보서륜、록초서반5.0~200.0μg·L-1,지서반10.0~500.0μg·L-1,록미파명20.0~500.0μg·L-1,오사서반7.5~2000μg·L-1,상관계수균대우0.9994;최저검측한분별위:아보서륜1.5μg·L-1、록초서반1.4μg·L-1、지서반3.0μg·L-1、록미파명5.5μg·L-1、오사서반2.2μg·L-1;일내급일간정밀도(CV%)분별위2.2%~12.6%、2.1%~13.2%,편차-10.6%~14.6%,제취회수솔81.1%~100.1%。결론해법가용우림상혈장중록미파명화4충분이담류약물적동시검측,방법신영、령민、경제,결과준학、가고。
Aim To establish a novel,highly sensitive,rapid and cost-effective HPLC method to simultaneously determine tri-cyclic antidepressant clomipramine and four benzodiazepines of diazepam,alprazolam,clonazepam,oxazepam in human plasma pretreated by solid phase extraction.Methods The assay was achieved by using C8 column (4.6 mm ×1 50 mm,5 μm)kept at 45 ℃,mobile phase 73.2:26.8 V/V (50 mmol·L -1 ,pH 3.0 phosphate buffer:acetonitrile)with flow rate of 1 .2 ml· min -1 ,and UV detection was set at λ220 nm.Solid phase ex-traction was performed on C1 cartridges.Results The calibra-tion curve was demonstrated to be linear (r >0.9994)in the ranges of 5 ~200 μg·L -1 for alprazolam and clonazepam,1 0 ~500 μg·L -1 for diazepam,20 ~500 μg· L -1 for clomipra-mine,and 7.5 ~2000 μg·L -1 for oxazepam;the limit of detec-tion (LOD)was 1 .5,1 .4,3.0,5.5 and 2.2 μg·L -1 for al-prazolam,clonazepam,diazepam,clomipramine and oxazepam respectively.Intra-day and inter-day precision revealed a coeffi-cient of variation of 2.2% ~1 2.6% and 2.1 % ~1 3.2%,re-spectively.Extraction yield ranged from 81 .1 % ~1 00.1 % for all analytes.Conclusion The developed method is accurate, reproducible,convenient,and suitable for routine therapeutic drug monitoring of clomipramine and the four benzodiazepines.